Free Trial

Xometry, Inc. (NASDAQ:XMTR) Holdings Decreased by Allspring Global Investments Holdings LLC

Xometry logo with Industrials background

Allspring Global Investments Holdings LLC trimmed its holdings in Xometry, Inc. (NASDAQ:XMTR - Free Report) by 4.5% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 209,149 shares of the company's stock after selling 9,926 shares during the period. Allspring Global Investments Holdings LLC owned 0.42% of Xometry worth $5,243,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in the business. GAMMA Investing LLC raised its holdings in shares of Xometry by 160.1% in the 1st quarter. GAMMA Investing LLC now owns 1,004 shares of the company's stock worth $25,000 after purchasing an additional 618 shares during the period. Canada Pension Plan Investment Board purchased a new position in shares of Xometry in the 4th quarter worth about $38,000. Comerica Bank raised its holdings in shares of Xometry by 195.1% in the 4th quarter. Comerica Bank now owns 1,133 shares of the company's stock worth $48,000 after purchasing an additional 749 shares during the period. CoreCap Advisors LLC purchased a new position in shares of Xometry in the 4th quarter worth about $51,000. Finally, SBI Securities Co. Ltd. purchased a new position in shares of Xometry in the 4th quarter worth about $73,000. 97.31% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Xometry

In other Xometry news, Director Emily Rollins sold 10,041 shares of Xometry stock in a transaction that occurred on Friday, May 9th. The stock was sold at an average price of $30.70, for a total transaction of $308,258.70. Following the sale, the director directly owned 11,105 shares in the company, valued at $340,923.50. The trade was a 47.48% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Randolph Altschuler sold 9,332 shares of the business's stock in a transaction that occurred on Wednesday, July 2nd. The shares were sold at an average price of $32.39, for a total value of $302,263.48. Following the completion of the sale, the chief executive officer owned 319,602 shares of the company's stock, valued at $10,351,908.78. This trade represents a 2.84% decrease in their ownership of the stock. The disclosure for this sale can be found here. 9.66% of the stock is owned by insiders.

Xometry Stock Up 2.6%

XMTR stock traded up $0.89 during midday trading on Wednesday, hitting $35.53. 778,204 shares of the company's stock were exchanged, compared to its average volume of 612,732. The company has a current ratio of 3.74, a quick ratio of 3.70 and a debt-to-equity ratio of 0.91. Xometry, Inc. has a 12-month low of $11.33 and a 12-month high of $45.33. The firm has a 50 day moving average price of $32.79 and a 200-day moving average price of $31.20. The stock has a market capitalization of $1.80 billion, a price-to-earnings ratio of -35.89 and a beta of 0.83.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on XMTR. Cantor Fitzgerald raised their price objective on Xometry from $20.00 to $21.00 and gave the stock an "underweight" rating in a report on Wednesday, May 7th. The Goldman Sachs Group raised their target price on Xometry from $30.00 to $33.00 and gave the company a "buy" rating in a report on Thursday, May 8th. Royal Bank Of Canada raised their target price on Xometry from $32.00 to $36.00 and gave the company a "sector perform" rating in a report on Wednesday, May 7th. JPMorgan Chase & Co. raised their target price on Xometry from $36.00 to $38.00 and gave the company an "overweight" rating in a report on Tuesday, June 3rd. Finally, UBS Group raised their target price on Xometry from $33.00 to $35.00 and gave the company a "neutral" rating in a report on Wednesday, May 7th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and six have issued a buy rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $35.78.

View Our Latest Research Report on Xometry

Xometry Profile

(Free Report)

Xometry, Inc operates an online marketplace that enables buyers to source custom-manufactured parts and assemblies in the United States and internationally. It provides computer numerical control manufacturing, sheet metal forming, and sheet cutting; 3D printing, including fused deposition modeling, direct metal laser sintering, PolyJet, stereolithography, selective laser sintering, binder jetting, carbon digital light synthesis, multi jet fusion, and lubricant sublayer photo-curing; and die casting, stamping, injection molding, urethane casting, tube cutting, and tube bending, as well as finishing services, rapid prototyping, and high-volume production services.

Featured Stories

Institutional Ownership by Quarter for Xometry (NASDAQ:XMTR)

Should You Invest $1,000 in Xometry Right Now?

Before you consider Xometry, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xometry wasn't on the list.

While Xometry currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines